Sphingolipids in anticancer therapy

被引:32
作者
Padrón, JM
机构
[1] Hosp Univ NS Candelaria, Inst Canario Invest Canc, Unidad Invest, Santa Cruz de Tenerife 38010, Spain
[2] Red Temat Invest Cooperat Ctr Canc, Inst Canario Invest Canc, Santa Cruz de Tenerife 38010, Spain
[3] Univ La Laguna, Inst Univ Bioorgan Antonio Gonzalez, E-38206 San Cristobal la Laguna, Spain
关键词
sphingolipid analogs; sphingosine; ceramide; apoptosis; signal transduction; anticancer drugs; structure-activity relationships; drug design;
D O I
10.2174/092986706776055553
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingolipids constitute a broad class of compounds with many biological functions. The sphingolipid metabolites ceramide and sphingosine are potent apoptosis inducers and produce cell cycle arrest, whereas sphingosine-1-phosphate promotes cellular growth and differentiation. Herein, the effects of sphingolipids and their analogs on diverse signaling pathways implicated in the apoptotic process are highlighted. The relatively simple chemical structure of these compounds has led to several strategies for their total synthesis. Those methods have contributed to the development and biological study of several analogs that present diverse degree of modification from the original structure. This article catalogues many of the recently developed synthetic analogs that act on diverse aspects of sphingolipid metabolism. A description of known enzyme inhibitors of the sphigolipids pathway is also given. Finally, diverse new sphingolipid-like antitumor agents isolated from marine sources are presented. This contribution opens the way for future development of new sphingolipid analogs that might be useful in cancer chemotherapy.
引用
收藏
页码:755 / 770
页数:16
相关论文
共 168 条
  • [121] Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A
    Ruvolo, PP
    Deng, XM
    Ito, T
    Carr, BK
    May, WS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (29) : 20296 - 20300
  • [122] PARTIAL INHIBITION OF MULTIDRUG-RESISTANCE BY SAFINGOL IS INDEPENDENT OF MODULATION OF P-GLYCOPROTEIN SUBSTRATE ACTIVITIES AND CORRELATED WITH INHIBITION OF PROTEIN-KINASE-C
    SACHS, CW
    SAFA, AR
    HARRISON, SD
    FINE, RL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) : 26639 - 26648
  • [123] Targeting ceramide metabolism - a strategy for overcoming drug resistance
    Sanchenkov, A
    Litvak, DA
    Cabot, MC
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (05): : 347 - 357
  • [124] Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases
    Schmelz, EM
    Dombrink-Kurtzman, MA
    Roberts, PC
    Kozutsumi, Y
    Kawasaki, T
    Merrill, AH
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 148 (02) : 252 - 260
  • [125] FTY720 inhibits tumor growth and angiogenesis
    Schmid, G
    Guba, M
    Papyan, A
    Ischenko, I
    Brückel, M
    Bruns, CJ
    Jauch, KW
    Graeb, C
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (01) : 110 - 111
  • [126] Schwartz GK, 1997, CLIN CANCER RES, V3, P537
  • [127] POTENTIATION OF APOPTOSIS BY TREATMENT WITH THE PROTEIN-KINASE C-SPECIFIC INHIBITOR SAFINGOL IN MITOMYCIN C-TREATED GASTRIC-CANCER CELLS
    SCHWARTZ, GK
    HAIMOVITZFRIEDMAN, A
    DHUPAR, SK
    EHLEITER, D
    MASLAK, P
    LAI, L
    LOGANZO, F
    KELSEN, DP
    FUKS, Z
    ALBINO, AP
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (18) : 1394 - 1399
  • [128] Selzner M, 2001, CANCER RES, V61, P1233
  • [129] Apoptotic activities of C2-ceramide and C2-dihydroceramide homologues against HL-60 cells
    Shikata, K
    Niiro, H
    Azuma, H
    Ogino, K
    Tachibana, T
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (13) : 2723 - 2728
  • [130] Synthesis of non-natural C2-homo-ceramide and its apoptotic activity against HL-60 cells
    Shikata, K
    Niiro, H
    Azuma, H
    Tachibana, T
    Ogino, K
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (04) : 613 - 616